ISSN 2639-9431
Vol. 4, Issue 2, 2021June 27, 2021 EDT
ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2
ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2
Articles in Vol. 4, Issue 2, 2021
Vol. 4, Issue 2, 2021
- Cellular uptake of nanoparticles: Involvement of caveolae?Tore SkotlandTore Geir IversenKirsten Sandvig
- Nanotechnology to deliver cannabinoids in dermatologyNagasai C. AdusumilliElizabeth L. HazukaAdam J. Friedman
- Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19Andrei SommerHorst-Dieter FörsterlingKurt NaberRamasamy Pitchappan
- ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2Barbara PoddesuGiulia CugiaFranco LoriDavide De Forni
Poddesu, Barbara, Giulia Cugia, Franco Lori, and Davide De Forni. 2021. “ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2.” Precision Nanomedicine 4 (2): 801–4. https://doi.org/10.33218/001c.25173.